These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 19609106

  • 1. Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.
    Priyadarshani A.
    J Endocrinol Invest; 2009 Nov; 32(10):837-43. PubMed ID: 19609106
    [Abstract] [Full Text] [Related]

  • 2. RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies.
    Ruiz A, Aguilar R, Tébar AM, Gaytán F, Sánchez-Criado JE.
    Biol Reprod; 1996 Dec; 55(6):1284-91. PubMed ID: 8949885
    [Abstract] [Full Text] [Related]

  • 3. Endocrine and morphological features of cystic ovarian condition in antiprogesterone RU486-treated rats.
    Sánchez-Criado JE, Sánchez A, Ruiz A, Gaytán F.
    Acta Endocrinol (Copenh); 1993 Sep; 129(3):237-45. PubMed ID: 8212989
    [Abstract] [Full Text] [Related]

  • 4. Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats.
    Mohammed S, Sundaram V, Zyuzikov N.
    J Ovarian Res; 2021 Feb 05; 14(1):26. PubMed ID: 33546719
    [Abstract] [Full Text] [Related]

  • 5. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
    Rajan RK, M SS, Balaji B.
    Pharm Biol; 2017 Dec 05; 55(1):242-251. PubMed ID: 27927075
    [Abstract] [Full Text] [Related]

  • 6. Ovary mediates the effects of RU486 given during proestrus on the diestrous secretion of luteinizing hormone in the rat.
    Tébar M, Ruíz A, Bellido C, Sánchez-Criado JE.
    Biol Reprod; 1996 Jun 05; 54(6):1266-70. PubMed ID: 8724354
    [Abstract] [Full Text] [Related]

  • 7. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC.
    J Clin Endocrinol Metab; 2000 Nov 05; 85(11):4047-52. PubMed ID: 11095431
    [Abstract] [Full Text] [Related]

  • 8. Total flavonoids extracted from Nervilia Fordii function in polycystic ovary syndrome through IL-6 mediated JAK2/STAT3 signaling pathway.
    Zhou Y, Lv L, Liu Q, Song J.
    Biosci Rep; 2019 Jan 31; 39(1):. PubMed ID: 30463907
    [Abstract] [Full Text] [Related]

  • 9. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
    Ryan GE, Malik S, Mellon PL.
    Endocrinology; 2018 Apr 01; 159(4):1734-1747. PubMed ID: 29471436
    [Abstract] [Full Text] [Related]

  • 10. Hormonal effects of flutamide in young women with polycystic ovary syndrome.
    De Leo V, Lanzetta D, D'Antona D, la Marca A, Morgante G.
    J Clin Endocrinol Metab; 1998 Jan 01; 83(1):99-102. PubMed ID: 9435423
    [Abstract] [Full Text] [Related]

  • 11. Ovulatory effects of flutamide in the polycystic ovary syndrome.
    Paradisi R, Fabbri R, Battaglia C, Venturoli S.
    Gynecol Endocrinol; 2013 Apr 01; 29(4):391-5. PubMed ID: 23327685
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models.
    Kavousipour S, Koohnavard F, Shahbazi B, Eftekhar E, Ahmadi K.
    Biomed Pharmacother; 2024 May 01; 174():116504. PubMed ID: 38552442
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O, Gordon K, Williams RF, Hodgen GD.
    Contraception; 1996 Jan 01; 53(1):55-64. PubMed ID: 8631191
    [Abstract] [Full Text] [Related]

  • 17. Effects of octamethylcyclotetrasiloxane (D4) on the luteinizing hormone (LH) surge and levels of various reproductive hormones in female Sprague-Dawley rats.
    Quinn AL, Dalu A, Meeker LS, Jean PA, Meeks RG, Crissman JW, Gallavan RH, Plotzke KP.
    Reprod Toxicol; 2007 Jun 01; 23(4):532-40. PubMed ID: 17418525
    [Abstract] [Full Text] [Related]

  • 18. [Study on the oxidative stress in the ovaries of a rat model of polycystic ovary].
    Gong J, Wu DB, Zhang LL, Li J, Zhao X, Zhang D.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar 01; 46(2):238-42, 247. PubMed ID: 25924437
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The antiprogestin RU486 dissociates LH and FSH secretion in male rats: evidence for direct action at the pituitary level.
    Sánchez-Criado JE, Bellido C, Tébar M, Ruiz A, Gonzalez D.
    J Endocrinol; 1999 Feb 01; 160(2):197-203. PubMed ID: 9924188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.